Home
Conditions
Neoplasm, Residual

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

207 public trials 79 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Active, not recruiting

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

NCT05219734

Conditions: Bladder Cancer, Bronchial Neoplasms, Cancer, +34 more
Locations: Columbus Regional Health Columbus, Indiana, United States

Onslow Radiation Jacksonville, North Carolina, United States

View Trial Details

Active, not recruiting

Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant

NCT03459170

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancy, +16 more
Locations: San Matteo Hospital Pavia, Italy

IRCCS Ospedale Pediatrico Bambino Gesù Rome, Italy

Ospedale Infantile Regina Margherita Turin, Italy

View Trial Details

Completed

Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease

NCT02458014

Conditions: Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Non-invasive Diagnostics and Monitoring of MRD and Clonal Evolution in Waldenström's Macroglobulinemia and in IgM-MGUS

NCT03521596

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Divisione di Ematologia Ospedale Niguarda Milan, MI, Italy

SOS Ematologia Ospedale C. Massaia Asti, Italy

IRCCS Istituto Tumori Giovanni Paolo II - UOC Ematologia Bari, Italy

AOU Università degli Studi della Campania Luigi Vanvitelli Naples, Italy

View all 15 locations

View Trial Details

Completed

Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

NCT04674306

Conditions: Breast Diseases, Breast Neoplasms, Neoplasm, Residual, +11 more
Locations: Cleveland Clinic, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

NCT07692607

Conditions: Autologous Hematopoietic Stem Cell Transplant, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: The Catholic University of Korea Seoul St.Mary's Hospital Seoul, South Korea

View Trial Details

Completed

Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery

NCT07567573

Conditions: Adnexal Diseases, Advanced-stage Ovarian Cancer, D010051, +24 more
Locations: European Society of Gynaecological Oncology Aisbl Brussels, Belgium

View Trial Details

Completed

Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia

NCT05987696

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Completed

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

NCT05429320

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations: Hartford Healthcare ALLIANCE (Data collection only) Hartford, Connecticut, United States

BAPTIST ALLIANCE - MCI (Data collection only) Miami, Florida, United States

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

View Trial Details

Completed

Lenalidomide With or Without Ixazomib Citrate and Dexamethasone in Treating Patients With Residual Multiple Myeloma After Donor Stem Cell Transplant

NCT02389517

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: University of Chicago Chicago, Illinois, United States

View Trial Details

Neoplasm, Residual

Neoplasm, Residual trial results

Related conditions